Turkish Real Life Atrial Fibrillation in Clinical Practice: TRAFFIC Study

dc.authoridaksu, ugur/0000-0003-0918-5032
dc.authoridAKSAKAL, Emrah/0000-0001-5765-4281
dc.authoridASTARCIOGLU, MEHMET ALI/0000-0001-8577-9890
dc.authoridOz, Melih/0000-0003-0574-5776
dc.authorwosidaksu, ugur/AAA-3562-2020
dc.authorwosidbabur guler, gamze/HKN-4198-2023
dc.authorwosidAKSAKAL, Emrah/AAA-3576-2020
dc.authorwosidÜlgen Kunak, Ayşegül/IZQ-0059-2023
dc.authorwosidBaşaran, Özcan/KIM-2166-2024
dc.contributor.authorKarabay, Can Yucel
dc.contributor.authorTasolar, Hakan
dc.contributor.authorKunak, Aysegul Ulgen
dc.contributor.authorCap, Murat
dc.contributor.authorAstarcioglu, Mehmet Ali
dc.contributor.authorSen, Taner
dc.contributor.authorKaplan, Mehmet
dc.date.accessioned2024-08-04T20:55:05Z
dc.date.available2024-08-04T20:55:05Z
dc.date.issued2024
dc.departmentİnönü Üniversitesien_US
dc.description.abstractBackground: Atrial fibrillation (AF) is the most prevalent cardiac arrhythmia worldwide and is associated with an increased risk of thromboembolism, ischemic stroke, impaired quality of life, and mortality. The latest research that shows the prevalence and incidence of AF patients in Turkiye was the Turkish Adults' Heart Disease and Risk Factors study, which included 3,450 patients and collected data until 2006/07.The Turkish Real Life Atrial Fibrillation in Clinical Practice (TRAFFIC) study is planned to present current prevalence data, reveal the reflection of new treatment and risk approaches in our country, and develop new prediction models in terms of outcomes. Methods: The TRAFFIC study is a national, prospective, multicenter, observational registry. The study aims to collect data from at least 1900 patients diagnosed with atrial fibrillation, with the participation of 40 centers from Turkiye. The following data will be collected from patients: baseline demographic characteristics, medical history, vital signs, symptoms of AF, ECG and echocardiographic findings, CHADS2VASC2 and HAS -BLED (1 -year risk of major bleeding) risk scores, interventional treatments, antithrombotic and antiarrhythmic medications, or other medications used by the patients. For patients who use warfarin, international normalized ratio levels will be monitored. Follow-up data will be collected at 6, 12, 18, and 24 months. Primary endpoints are defined as systemic embolism or major safety endpoints (major bleeding, clinically relevant nonmajor bleeding, and minor bleeding as defined by the International Society on Thrombosis and Hemostasis). The main secondary endpoints include major adverse cardiovascular events (systemic embolism, myocardial infarction, and cardiovascular death), all -cause mortality, and hospitalizations due to all causes or specific reasons. Results: The results of the 12 -month follow-up of the study are planned to be shared by the end of 2023. Conclusion: The TRAFFIC study will reveal the prevalence and incidence, demographic characteristics, and risk profiles of AF patients in Turkiye. Additionally, it will provide insights into how current treatments are reflected in this population. Furthermore, risk prediction modeling and risk scoring can be conducted for patients with AF.en_US
dc.identifier.doi10.14744/AnatolJCardiol.2023.3616
dc.identifier.endpage93en_US
dc.identifier.issn2149-2263
dc.identifier.issn2149-2271
dc.identifier.issue2en_US
dc.identifier.pmid38168008en_US
dc.identifier.scopus2-s2.0-85184755603en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.startpage87en_US
dc.identifier.urihttps://doi.org/10.14744/AnatolJCardiol.2023.3616
dc.identifier.urihttps://hdl.handle.net/11616/101809
dc.identifier.volume28en_US
dc.identifier.wosWOS:001196207100004en_US
dc.identifier.wosqualityN/Aen_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherKare Publen_US
dc.relation.ispartofAnatolian Journal of Cardiologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectArrhythmiasen_US
dc.subjectatrial fibrillation/flutteren_US
dc.subjectatrial fibrillationen_US
dc.subjectbleedingen_US
dc.subjectcatheter ablationen_US
dc.titleTurkish Real Life Atrial Fibrillation in Clinical Practice: TRAFFIC Studyen_US
dc.typeArticleen_US

Dosyalar